Hong Kyu Kim1, Hoon Yub Kim1, Young Jun Chai2, Gianlorenzo Dionigi3, Eren Berber4, Ralph P Tufano5. 1. Department of Surgery, KUMC Thyroid Center, Korea University Hospital, Korea University College of Medicine. 2. Department of Surgery, Seoul National University Boramae Medical Center, Seoul, Republic of Korea. 3. Department of Human Pathology in Adulthood and Childhood "G. Barresi," University Hospital "G. Martino," Division of Endocrine Surgery, University of Messina, Messina, Italy. 4. Center for Endocrine Surgery, Cleveland Clinic, Cleveland, OH. 5. Department of Otolaryngology-Head and Neck Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD.
Abstract
INTRODUCTION: The surgical outcomes for procedures using da Vinci Xi were compared with those of da Vinci Si in transoral robotic thyroidectomy (TORT). MATERIALS AND METHODS: The medical records were retrospectively reviewed. Patients were classified into 2 groups (da Vinci Xi vs. da Vinci Si) and surgical outcomes were analyzed. RESULTS: Each group comprised 58 patients. The postoperative pain scores at operation day 0 were lower, the hospital stays were shorter, and the number of retrieved central lymph nodes in the papillary thyroid carcinoma patients were greater in the Xi group than in the Si group. There were no significant differences between groups in either vocal cord palsy or hypoparathyroidism rates. There were no TORT-specific complications in the Xi group. There was no conversion to endoscopic or conventional open thyroid surgery in both groups. CONCLUSIONS: TORT could be performed safely with both da Vinci Si and Xi systems.
INTRODUCTION: The surgical outcomes for procedures using da Vinci Xi were compared with those of da Vinci Si in transoral robotic thyroidectomy (TORT). MATERIALS AND METHODS: The medical records were retrospectively reviewed. Patients were classified into 2 groups (da Vinci Xi vs. da Vinci Si) and surgical outcomes were analyzed. RESULTS: Each group comprised 58 patients. The postoperative pain scores at operation day 0 were lower, the hospital stays were shorter, and the number of retrieved central lymph nodes in the papillary thyroid carcinomapatients were greater in the Xi group than in the Si group. There were no significant differences between groups in either vocal cord palsy or hypoparathyroidism rates. There were no TORT-specific complications in the Xi group. There was no conversion to endoscopic or conventional open thyroid surgery in both groups. CONCLUSIONS: TORT could be performed safely with both da Vinci Si and Xi systems.